BiocurePharm is Biopharmaceutical venture company that has a target to overcome incurable disease.

Nucleic acid molecules isolated from C10orf96 gene as cancer specific antigen gene, the antigen and use of them(No. 10-2005-0100395)

Identification of C6orf10 gene, specific tumor antigen, by means of the selection of cDNA library with lung cancer patient sera and the use of the antigen in the diagnosis and treatment of tumors(No.10-2005-0100401).

Identification of LOC122258 gene, specific tumor antigen, by means of the selection of cDNA library with colon cancer patient sera and the use of the antigen in the diagnosis and treatment of tumors (No. 10-2005-0100408)

Expression system of human serum albumin-TIMP-2 fusion protein and recombinant human serum albumin-TIMP-2 protein(No. 10-0441384-00-00)

Method for preparation of therapeutic B cells against autoimmune diseases which are induced by autoimmune cytotoxicity(No. PCT/KR/005245)

Human serum albumin-TIMP2 fusion protein, a polynuleotide encoding the same and a method of producing the human serum albumin-TIMP2 fusion protein(No. PCT/KR/00015)